title: The treatment of ovarian cancer with a gene modified cancer vaccine: a phase I study.
authors.affiliation: Tulane University Medical Center, University of Rochester Medical Center, USA.
authors.forename: S M
authors.initials: SM
authors.lastname: Freeman
authors.forename: C
authors.initials: C
authors.lastname: McCune
authors.forename: W
authors.initials: W
authors.lastname: Robinson
authors.forename: C N
authors.initials: CN
authors.lastname: Abboud
authors.forename: G N
authors.initials: GN
authors.lastname: Abraham
authors.forename: C
authors.initials: C
authors.lastname: Angel
authors.forename: A
authors.initials: A
authors.lastname: Marrogi
mesh_terms: D017690:Cell Transplantation; D002985:Clinical Protocols; D005260:Female; D006801:Humans; D007167:Immunotherapy; D010051:Ovarian Neoplasms / Q000473:pathology / Q000628:therapy*; D012107:Research Design; D014407:Tumor Cells, Cultured; D014612:Vaccines / Q000276:immunology
chemical_list: D014612:Vaccines